Angiotensin II, a new vasopressor for septic shock, coming soon (probably)
PulmCCM - September 8, 2017
"La Jolla Pharmaceutical Company, makers of LJPC-501 (no trade name yet), announced the FDA has begun reviewing their fast-track application for approval of angiotensin II. The proposed indications are septic shock and other vasodilatory shock despite provision of fluids and other vasopressors."